UniQure gene therapy shows rise in blood-clotting protein levels

Drug developer UniQure NV said on Friday its gene therapy to treat hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a small study.

Source: Reuters: Health - February 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news